Company / Free Cash Flow per Share
ALNYLAM PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$3.60
FY2025
5-year range
-$5.70 / $3.60
FY2021-FY2025
Trend
+1163.2%
vs FY2024
Sector context
#24 of 192
Health Care
What the data says
Free Cash Flow per Share changed +1163% YoY in FY2025, a notable deviation from the 9-year average annual change of +111%.
Based on SEC 10-K filings.
3.60 in FY2025. Top quartile in the Health Care sector.
Improved from $0.34 to $3.60 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 192This company $3.60 Sector average $3.32
▼
+8.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 1163.2% year-over-year.
- Ranks #24 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.37 (distress zone, below 1.8 threshold)
- Negative profit margin: -12.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.60 | +1163.2% |
| FY2024 | -$0.34 | -200.0% |
| FY2023 | $0.34 | +105.9% |
| FY2022 | -$5.70 | -58.6% |
| FY2021 | -$3.60 | +41.5% |
| FY2020 | -$6.15 | -27.7% |
| FY2019 | -$4.81 | -28.9% |
| FY2018 | -$3.74 | +30.5% |
| FY2017 | -$5.38 | -23.7% |
| FY2016 | -$4.35 | -80.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026